Terminology Service for NFDI4Health
All terms in MESH
| Label | Id | Description |
|---|---|---|
| class-I restricted T cell-associated molecule | C408522 | |
| Sinus Tarsi Syndrome | C000604661 | |
| SUR1 protein, Candida albicans | C408523 | |
| 4-methylphenylquinoline-2-carboxylate | C000604662 | |
| N'-(4-methoxybenzylidene)benzohydrazide | C000604663 | |
| chloralkylene 12 | C012820 | |
| chlorasquin | C012821 | |
| chlorfenpropmethyl | C012822 | |
| 2-chlorobenzoyl-bovine gamma globulin | C012823 | |
| glycine chloramine | C012826 | |
| IST-FS 29 | C408503 | |
| oncocalyxone A | C408504 | |
| oncocalyxone C | C408505 | |
| doxorubicin-gallium-transferrin conjugate | C408506 | |
| DZ 3358 | C408507 | |
| AhpA protein, Pasteurella multocida | C408508 | |
| 5-chloro-4-oxo-L-norvaline | C012828 | |
| chloroxuron | C012829 | |
| Optic Atrophy, Autosomal Dominant | D029241 | [Dominant optic atrophy is a hereditary optic neuropathy causing decreased visual acuity, color vision deficits, a centrocecal scotoma, and optic nerve pallor (Hum. Genet. 1998; 102: 79-86). Mutations leading to this condition have been mapped to the OPA1 gene at chromosome 3q28-q29. OPA1 codes for a dynamin-related GTPase that localizes to mitochondria.] |
| Mitochondrial Diseases | D028361 | [Diseases caused by abnormal function of the MITOCHONDRIA. They may be caused by mutations, acquired or inherited, in mitochondrial DNA or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes.] |